Pre-Conference Symposia – International Stroke Conference
ISC Sessions: February 7–9, 2024
Phoenix Convention Center | Phoenix, Arizona
Choose the symposia best for you!
Jump to:
HEADS-UP Programming
Tuesday, February 7, 2023
8:30 am - 5:45 pm
Time | Activity |
---|---|
Moderators | Bruce Ovbiagele, MD, PhD, MPH, FAHA, San Francisco, CA Amytis Towfighi, MD, Los Angeles, CA |
8:30 a.m. | Welcome, Pre-Test, Policy Maker Intro Moderator: Bruce Ovbiagele, MD MSc MAS MBA MLS FAHA |
8:35 a.m. | Distinguished Policy Maker Lecture Eliseo Perez-Stable, MD, San Francisco, CA |
8:50 am | Q&A |
8:55 a.m. | Implementation Science Approaches and Tools |
9:10 a.m. | Q&A |
9:05 a.m. | Social Determinants of Health and Information Research |
9:30 a.m. | Q&A |
9:35 a.m. | Introduction of the Edgar J Kenton III Lecture Nneka Ifejika, MD, MPH, Dallas, Texas |
9:40 a.m. | Edgar J Kenton III Lecture Cheryl D Bushnell, MD, MHS, Winston-Salem, NC |
9:55 a.m. | Q&A |
10:00 a.m. | Break |
10:10 a.m. | Implementation Science to Address Disparities in Acute Stroke Prognoses Sandy Middleton, PhD, Darlinghurst, Australia |
10:25 a.m. | Q&A |
10:30 a.m. | Think Tank (Career Development Session) Panelists: Barbara G Vickery, MD, MPH, New York, NY Janet A Prvu Bettger, ScD, FAHA, Durham, NC James F Burke, MD, Columbus, OH Mathew J Reeves, PhD, East Lansing, MI |
10:30 a.m. | Identifying and Addressing Racial Disparities in Stroke Care: Insights from a Contemporary National Quality Improvement Initiative M Carter Denny, MD, MPH, Washington, DC |
10:45 a.m. | Q&A |
10:52 a.m. | Title TBD Nicole Rosendale, MD, San Francisco, CA |
11:07 a.m. | Q&A |
11:15 a.m. | Title TBD Alexis N Simpkins, MD, PhD, MSCR, FAHA, Gainesville, FL |
11:30 a.m. | Q&A |
11:37 a.m. | Title TBD Charles Esenwa, MD, Bronx, NY |
12:00 Noon | Networking Lunch |
1:00 p.m. | HEADS-UP Poster Session 20 Poster Abstracts to be presented Please see complete list in HEADS-UP Schedule (PDF) Poster Professors: Richard T Benson Sr, MD, PhD, Bethesda, MD Cheryl D Bushnell, MD, MHS, Winston Salem, NC Michelle Nichols, PhD, RN, Charleston, SC Mayowa Owolabi, Dr.M, MBBS, MSc, FMCP, FAAN, FANA, FRCP, FAS, Ibadan, Nigeria Anjail Z Sharrief, MD, MPH, Houston, TX& |
3:00 p.m. | Break |
3:05 p.m. | Implementation Science to Bridge Differences in Posthospital Stroke Care and Outcomes Janet A Prvu Bettger, ScD, FAHA, Durham, NC |
3:20 p.m. | Q&A |
3:25 p.m. | Implementation Science for Health Equity in Stroke Rehabilitation Lisa Juckett, PhD, OTR/L, CHT, Columbus, OH |
3:40 pm | Q&A |
3:45 p.m. | Implementation Science to Overcome Disparities in Stroke Risk Factor Management |
4:00 p.m. | Building Momentum (Career Development Session) Panelists: Nicole R Gonzales, MD, Aurora, CO Karen C Johnston, MD, Charlottesville, VA Thabele M Leslie-Mazwi, MD, Seattle, WA Louise D McCullough, MD, PhD, FAHA, Houston, TX |
5:25 p.m | Closing Remarks, Post-test, & Adjourn Amytis Towfighi, MD, FAHA |
Stroke in the Real World
February 7, 2023
9:00 a.m. - 5:05 p.m.
Time | Activity |
---|---|
Moderators | Mollie McDermott, MD, MS, Ann Arbor, MI Theodore Wein MD, FRCPC, Mont-royal, QC, Canada |
9:00 a.m. | Howdy, Y'all! Mollie McDermott, MD, MS, Ann Arbor, MI |
9:05 a.m. | Hang Your Hat On It: Neurocritical Care for the Non-neurologist: Why Does NCC Exist? |
9:45 a.m. | As All Git-Out: Acute Blood Pressure Management after Ischemic Stroke and IPH |
10:15 a.m. | I'm Fixin' To: Sodium Disorders in NICU Patients: A Practical Approach Torrey Boland Birch, MD, Chicago, IL |
10:45 a.m. | Break |
11:00 a.m. | Debate: Hemicraniectomy: Pre-Emptive Wendy C. Ziai, MD, Baltimore, MD |
11:15 a.m. | Debate: Hemicraniectomy: Wait for Deterioration William Metcalf-Doetsch, MD, Chicago, IL |
11:30 a.m. | Ugly As Sin: Management of Complications after Thrombolysis and Thrombectomy Joshua N. Goldstein, MD, PhD, FAHA, Boston, MA |
12:05 p.m. | Ready and Rarin' To Go: Anticoagulant Reversal in ICH Jennifer Frontera, MD, Brooklyn, NY |
12:30 p.m. | Lunch |
1:30 p.m. | Debate: Mannitol for ICP Lauren H. Sansing, MD, New Haven, CT |
1:45 p.m. | Debate: Hypertonic Saline for ICP Ruchira M. Jha, MD, Phoenix, AZ |
2:00 p.m. | I'll Tell You What!: Care of the Post-Endarterectomy or Carotid Stent Patient Alejandro A. Rabinstein, MD, FAHA, Rochester, MN |
2:25 p.m. | Death Warmed Over: Brain Death and Neuroprognostication in the ICU |
2:55 p.m. | This Ain't My First Rodeo: Vasospasm Revisited Soojin Park, MD, FAHA FNCS, New York, NY |
3:20 p.m. | I Smell What You're Stepping In: Emerging ICU Stroke Therapies (Portable MRI) |
3:50 p.m. | Break |
4:05 p.m. | Bless Your Heart: APPs in the NICU Cecelia Ratay, DNP, Pittsburgh, PA |
4:30 p.m. | Debate: Multimodal Monitoring in the ICU: Yes Paul M. Vespa, MD, Los Angeles, CA |
4:45 p.m. | Debate: Multimodal Monitoring in the ICU: No Neha S. Dangayach, MD, Los Angeles, CA |
5:00 p.m. | It's Time to Put Out the Fire and Call in the Dogs Theodore Wein MD, FRCPC, Mont-royal, QC, Canada |
Stroke in the Lab World
Stroke in the Lab World: High-Dimensional Single Cell Analyses to Unravel the Complexities of Cerebrovascular Disease and Brain Health
February 7, 2023
9:00 a.m. - 5:30 p.m.
This symposium is designed to be a deep-dive into single cell -omics techniques and other high-dimensional single cell analyses as applied to research in cerebrovascular diseases and brain health. Topics include methodologies in single cell transcriptomics as well as applied research presentations on vasculature development, neurodegenerative diseases, ischemic stroke, intracranial stenosis, intracerebral hemorrhage, hypertension and cognition, among other topics. There will also be a panel discussion focused on opportunities and limitations of high dimensional single cell analysis techniques. In addition to senior faculty talks, the symposium includes presentations from early career faculty and trainees who were selected to meet our mission of fostering young investigators to further advance the stroke field.
After participating in this activity, participants will be able to:
- Compare the advantages of single cell transcriptomics and other single cell analysis methods.
- Explain the results of various studies applying high dimensional analyses at the single cell level.
- Describe cellular and molecular mechanisms involved in vulnerability to ischemia, hemorrhage, vascular remodeling, and neurodegeneration.